First semester starts well for FHNW Campus Muttenz
The semester has got off to a successful start at FHNW University of Applied Sciences and Arts Northwestern Switzerland’s new Campus Muttenz. With 4,000 students and 800 employees, the campus comprises five schools.
FHNW, Campus Muttenz (img: Ralf Dümpelmann)
This week saw the opening of Campus Muttenz, giving the FHNW University of Applied Sciences and Arts Northwestern Switzerland one campus in each of its four supporting cantons.
The new campus comprises five school: the School of Life Sciences, the School of Architecture, Civil Engineering and Geomatics, the School of Social Work, the Pedagogical School and the trinational mechatronics programme at the School of Technology. It employs around 800 staff and has some 4,000 students, according to a press release.
Following four years of construction and investment of around 302 million Swiss francs, the campus at Polyfeld in Muttenz has got off to a good start. With no capacity issues reported by the SBB or the regional transport authorities, the staggered start of classes proved successful.
Muttenz is FHNW’s first campus in the Basel area. The canton has the relatively largest proportion of students, at around 29 per cent, followed by the canton of Solothurn with 28 per cent, the canton of Aargau with 24 per cent and the canton of Basel-Stadt with 19 per cent. The FHNW comprises nine schools in total.
Share this article
You might also be interested in
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.Read More